Breaking News Instant updates and real-time market news.

NBRV

Nabriva Therapeutics

$2.31

-0.09 (-3.75%)

07:04
11/06/18
11/06
07:04
11/06/18
07:04

Nabriva Therapeutics reports Q3 EPS (90c), consensus (29c)

Reports Q3 revenue $1.468M, consensus $2.3M.

  • 27

    Nov

NBRV Nabriva Therapeutics
$2.31

-0.09 (-3.75%)

05/31/18
CANT
05/31/18
NO CHANGE
Target $16
CANT
Overweight
Nabriva Therapeutics valuation 'hard to resist,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen says she left meetings with Nabriva Therapeutics management even more convinced that the market opportunity for lefamulin is underappreciated. Nabriva Therapeutics shares have been weak since the company announced positive data from its second Phase 3 study, Chen tells investors in a research note titled "NBRV Hard to Resist At Its Current Valuation." She sees no fundamental reason for the weakness and keeps an Overweight rating on the shares with a $16 price target.
05/31/18
NORL
05/31/18
INITIATION
Target $17.5
NORL
Outperform
Nabriva Therapeutics initiated with an Outperform at Northland
Northland initiated Nabriva Therapeutics with an Outperform and $17.50 price target.
08/27/18
BOFA
08/27/18
NO CHANGE
Target $5
BOFA
Buy
Nabriva Therapeutics price target lowered to $5 from $9 at BofA/Merrill
BofA/Merrill analyst Jason Gerberry lowered his price target on Nabriva Therapeutics to $5, citing his lower expected probability of success of 60% vs. 75% prior in its recently acquired CONTEPO for complicated urinary tract infection. The analyst says the program's main risk is an "imbalance of liver enzyme elevation while a slightly higher dose reduces read -through from about a 45-year post-market EU safety". Gerberry now believes that CONTEPO is a "niche opportunity", and lowers his peak sales view to $50M from $80M prior. The analyst also keeps his Buy rating on Nabriva on valuation as well as the opportunity for its two FDA action dates for lefamulin and CONTEPO in the second half of 2019.
09/07/18
MSCO
09/07/18
INITIATION
Target $8
MSCO
Overweight
Nabriva Therapeutics resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz resumed coverage of Nabriva Therapeutics with an Overweight rating and a $8 price target, stating that its "first-in-class" antibiotics lefamulin and Contepo both have approvable Phase 3 data. He believes at current levels Nabriva shares are pricing in a "worst case scenario" for both antibiotics, but he sees it as likely that Nabriva exceeds the low expectations. Lebowitz forecasts risk-adjusted 2025 sales for lefamulin and Contepo of $228M and $33M, respectively.

TODAY'S FREE FLY STORIES

AMRN

Amarin

$17.73

0.31 (1.78%)

, NVS

Novartis

$90.51

(0.00%)

10:05
02/22/19
02/22
10:05
02/22/19
10:05
Rumors
Rumor moving shares of Amarin, Novartis »

Amarin early strength…

AMRN

Amarin

$17.73

0.31 (1.78%)

NVS

Novartis

$90.51

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 27

    Feb

  • 28

    Feb

  • 11

    Mar

  • 12

    Mar

  • 19

    Mar

INNT

Innovate Biopharmaceuticals

$1.99

-0.09 (-4.33%)

10:02
02/22/19
02/22
10:02
02/22/19
10:02
Hot Stocks
Innovate CEO Christopher Prior to depart, Sandeep Laumas to succeed »

Innovate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$19.52

0.12 (0.62%)

10:01
02/22/19
02/22
10:01
02/22/19
10:01
Hot Stocks
Breaking Hot Stocks news story on PG&E »

PG&E trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBI

Pitney Bowes

$7.65

0.63 (8.97%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Options
Pitney Bowes calls seeing interest as shares rally 7% »

Pitney Bowes calls seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    Mar

LTN

Union Acquisition Corp

$7.33

(0.00%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Hot Stocks
Union Acquisition Corp falls -13.5% »

Union Acquisition Corp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

ASPN

Aspen Aerogels

$3.25

-0.35 (-9.72%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Hot Stocks
Aspen Aerogels falls -9.4% »

Aspen Aerogels is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$8.66

-4.8 (-35.66%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Hot Stocks
Diplomat Pharmacy falls -35.4% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

SWM

Schweitzer-Mauduit

$39.98

5.29 (15.25%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Hot Stocks
Schweitzer-Mauduit rises 11.8% »

Schweitzer-Mauduit is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Mar

BYD

Boyd Gaming

$30.95

2.67 (9.44%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Hot Stocks
Boyd Gaming rises 9.6% »

Boyd Gaming is up 9.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$149.00

31.86 (27.20%)

10:00
02/22/19
02/22
10:00
02/22/19
10:00
Hot Stocks
Wayfair rises 27.1% »

Wayfair is up 27.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

10:00
02/22/19
02/22
10:00
02/22/19
10:00
General news
Treasury Action: yields are drifting lower, even as Wall Street opens in the green »

Treasury Action: yields…

10:00
02/22/19
02/22
10:00
02/22/19
10:00
General news
Breaking General news story  »

New York Federal Reserve…

10:00
02/22/19
02/22
10:00
02/22/19
10:00
General news
Breaking General news story  »

San Francisco Federal…

MORN

Morningstar

$126.83

-0.37 (-0.29%)

09:57
02/22/19
02/22
09:57
02/22/19
09:57
Earnings
Morningstar drops after admitting late 2018 market downturn hurt asset growth »

Morningstar last night…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$23.30

1.6 (7.37%)

, INTU

Intuit

$238.70

3.85 (1.64%)

09:55
02/22/19
02/22
09:55
02/22/19
09:55
Options
Early notable gainers among liquid option names on February 22nd »

Notable gainers among…

DLPH

Delphi Technologies

$23.30

1.6 (7.37%)

INTU

Intuit

$238.70

3.85 (1.64%)

EQT

EQT Corporation

$19.51

0.48 (2.52%)

CXO

Concho Resources

$106.07

2.38 (2.30%)

PXD

Pioneer Natural

$140.11

3.9 (2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 22

    May

  • 28

    May

ISRG

Intuitive Surgical

$555.58

5.59 (1.02%)

09:53
02/22/19
02/22
09:53
02/22/19
09:53
Technical Analysis
Technical Take: Intuitive Surgical has a large active bullish pattern »

On a 5-year weekly chart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$24.76

2 (8.79%)

09:51
02/22/19
02/22
09:51
02/22/19
09:51
Upgrade
iQIYI rating change  »

iQIYI upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MORN

Morningstar

$127.20

(0.00%)

09:50
02/22/19
02/22
09:50
02/22/19
09:50
Hot Stocks
Breaking Hot Stocks news story on Morningstar »

Morningstar trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$1.28

(0.00%)

09:50
02/22/19
02/22
09:50
02/22/19
09:50
Hot Stocks
Breaking Hot Stocks news story on Trillium Therapeutics »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

W

Wayfair

$143.50

26.36 (22.50%)

09:49
02/22/19
02/22
09:49
02/22/19
09:49
Recommendations
Wayfair analyst commentary  »

Wayfair's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 03

    Mar

ASTE

Astec

$39.41

(0.00%)

, TEX

Terex

$35.65

0.06 (0.17%)

09:48
02/22/19
02/22
09:48
02/22/19
09:48
Recommendations
Astec ticks higher after Baird discusses possible takeover by Terex »

Terex (TEX) delaying its…

ASTE

Astec

$39.41

(0.00%)

TEX

Terex

$35.65

0.06 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$43.05

-4.22 (-8.93%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Nevro falls -9.2% »

Nevro is down -9.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASPN

Aspen Aerogels

$3.60

(0.00%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Aspen Aerogels falls -12.8% »

Aspen Aerogels is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPLO

Diplomat Pharmacy

$8.86

-4.6 (-34.18%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
Diplomat Pharmacy falls -34.1% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

PAGS

PagSeguro Digital

$25.10

2.24 (9.80%)

09:47
02/22/19
02/22
09:47
02/22/19
09:47
Hot Stocks
PagSeguro Digital rises 11.1% »

PagSeguro Digital is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.